LGALS3BP and breast carcinoma: Galectin-3-binding protein was found to be increased in the control group, with a mean of 75263.2 pg/ml, compared to breast cancer group which had a mean of 23747.3 pg/ml and a p-value of <0.0001 (Fig 2C).